A urologist Valentina Grajales, MD, MS, specializes in urologic oncology including the surgical management of cancers of the prostate, bladder and kidney. Dr. Grajales serves as director of urological oncology at Emory University Hospital Midtown. As an attending physician, her practice locations include Emory Saint Joseph's Hospital and Winship Cancer Institute at Emory Midtown. She is fluent in Spanish.
Dr. Grajales is an assistant professor and serves as associate director for global health in the Department of Urology at Emory University School of Medicine.
Dr. Grajales received her medical degree from the University of Virginia School of Medicine. She earned a Masters of Science in Biochemistry and Molecular Biology from Georgetown University and spent a year at the National Institutes of Health investigating gynecological cancers and breast cancer. She completed her urology surgery residency at University of Pittsburgh Medical Center and her urologic oncology fellowship at University of Texas MD Anderson Cancer Center.
Titles & Roles
Assistant Professor, Department of Urology
Emory University School of Medicine
Associate Director for Global Health, Department of Urology
Emory University School of Medicine
Director of Urological Oncology
Emory University Hospital Midtown
Education & Training
Education
Fellowship, Urologic Oncology, 2024
MD Anderson Cancer Center
Residency, Urology, 2022
University of Pittsburg Medical Center
Internship, General Surgery, 2018
University of Pittsburg Medical Center
Medical Education, MD, 2016
University of Virginia Health System
Professional Memberships
Society of Women in Urology
American Urological Association
International Bladder Cancer Network
Research
Dr. Grajales' research interests include health services research and global health surgical research in urologic oncology particularly looking at improving access to care and reducing health disparities. In addition, she conducts clinical trials to develop novel treatment strategies for patients with bladder cancer.
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care.
Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to
all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations
behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful
for our patients, please click here.
